Stock Research for PFE

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PFE Stock Chart & Research Data

The PFE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PFE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PFE Due diligence Resources & Stock Charts

The PFE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PFE Detailed Price Forecast - CNN Money CNN View PFE Detailed Summary - Google Finance
Yahoo View PFE Detailed Summary - Yahoo! Finance Zacks View PFE Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PFE Trends & Analysis - Trade-Ideas Barrons View PFE Major Holders - Barrons
NASDAQ View PFE Call Transcripts - NASDAQ Seeking View PFE Breaking News & Analysis - Seeking Alpha
Spotlight View PFE Annual Report - CompanySpotlight.com OTC Report View PFE OTC Short Report - OTCShortReport.com
TradeKing View PFE Fundamentals - TradeKing Charts View PFE SEC Filings - Bar Chart
WSJ View Historical Prices for PFE - The WSJ Morningstar View Performance/Total Return for PFE - Morningstar
MarketWatch View the Analyst Estimates for PFE - MarketWatch CNBC View the Earnings History for PFE - CNBC
StockMarketWatch View the PFE Earnings - StockMarketWatch MacroAxis View PFE Buy or Sell Recommendations - MacroAxis
Bullish View the PFE Bullish Patterns - American Bulls Short Pains View PFE Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PFE Stock Mentions - StockTwits PennyStocks View PFE Stock Mentions - PennyStockTweets
Twitter View PFE Stock Mentions - Twitter Invest Hub View PFE Investment Forum News - Investor Hub
Yahoo View PFE Stock Mentions - Yahoo! Message Board Seeking Alpha View PFE Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PFE - SECform4.com Insider Cow View Insider Transactions for PFE - Insider Cow
CNBC View PFE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PFE - OTC Markets
Yahoo View Insider Transactions for PFE - Yahoo! Finance NASDAQ View Institutional Holdings for PFE - NASDAQ


Stock Charts

FinViz View PFE Stock Insight & Charts - FinViz.com StockCharts View PFE Investment Charts - StockCharts.com
BarChart View PFE Stock Overview & Charts - BarChart Trading View View PFE User Generated Charts - Trading View




Latest Financial News for PFE


Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Posted on Wednesday November 21, 2018

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Chris Boshoff, senior vice president and head, Immuno-Oncology, Early Development and Translational Oncology, at the Evercore ISI HealthConX Conference on Wednesday, November 28, 2018 at 8:45 a.m. EST. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com/investors beginning today. Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com/investors.


FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz
Posted on Wednesday November 21, 2018

The FDA accepts Allergan's (AGN) sNDA for the label expansion of its antibacterial medicine, Avycaz, to treat cUTI and cIAI in pediatric patients.


Why Pfizer’s Share Price Fell on November 20
Posted on Wednesday November 21, 2018

On November 20, Pfizer (PFE) closed at $43.53, which was 1.47% lower than its previous closing price. On November 19, Pfizer and Merck KGaA issued a press release announcing unfavorable results from the Phase 3 trial, JAVELIN Ovarian 200, evaluating avelumab in ovarian cancer indication.


5 Quality Blue Chips to Thrive in Bull and Bear Markets
Posted on Wednesday November 21, 2018

As the market grows increasingly turbulent and  economic outlooks become more cautious, investors are increasingly buying quality stocks, which by definition are stocks whose companies are not overly reliant on a robust economy for their performance. In the current environment, Walmart Inc. ( WMT), McDonald’s Corp. ( MCD), Pfizer Inc. ( PFE), Procter & Gamble Co. ( PG) and Amgen Inc. ( AMGN) have all received the quality stamp of approval by Citigroup, according to CNBC.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.